These six men oversee more than $120 billion in research and technology investments in the United States.
JOHN LAMATTINA is the president of Pfizer Global Research and Development. Pfizer, headquartered in New York, NY, has the pharmaceutical industrys largest R&D budget$7.7 billion last yearand one of the largest among all corporations. Trained as a chemist, LaMattina now oversees more than 12,500 scientists at eight major research campuses and other smaller facilities in five countries.
MICHAEL WYNNE is the acting undersecretary of defense for acquisition, technology, and logistics at the U.S. Department of Defense. He advises the secretary and deputy secretary of defense on acquisition, R&D, and advanced-technology matters. The militarys budget for R&D and advanced-technology testing and evaluation for fiscal year 2005 is $69 billion.
DON VALENTINE is a partner and the founder of Sequoia Capital, a leading technology venture capital firm in Menlo Park, CA. Sequoia completed 30 investment deals last year, making it one of the most active technology venture capital firms. Valentine founded the firm in 1972 and was an original investor in Apple Computer, Atari, and Oracle.
ANDREW VON ESCHENBACH is the director of the National Cancer Institute, the largest institute within the National Institutes of Health, with a 2005 budget of $4.8 billion. He is a urologic surgeon and a cancer survivor. He has made it a goal of his organization to eliminate suffering and death due to cancer by 2015.
THEODORE POEHLER is the vice provost for research at Johns Hopkins University, whose total research budget this year is about $1.2 billion, the largest among U.S. universities. Trained as an electrical engineer, Poehler has a bachelors and a masters degree and a PhD, all from Johns Hopkins, and has spent almost his entire professional career with the university.
STEVE MCGAW was Cingular Wirelesss head of corporate development and the chief negotiator behind its acquisition of AT&T Wireless last year, in a deal worth $41 billion. This was the largest technology acquisition in the United States last year, and it made Cingular the number one U.S. wireless provider. McGaw is now senior vice president, supply chain, at Cingular.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.